Adial Pharmaceuticals (ADIL) Net Margin (2022 - 2024)
Adial Pharmaceuticals' Net Margin history spans 3 years, with the latest figure at 245829800.0% for Q2 2024.
- For Q2 2024, Net Margin rose 24583037993.0% year-over-year to 245829800.0%; the TTM value through Dec 2024 reached 8015.12%, down 1992007.0%, while the annual FY2021 figure was 41775.98%, 39394362.0% up from the prior year.
- Net Margin for Q2 2024 was 245829800.0% at Adial Pharmaceuticals, up from 3933.34% in the prior quarter.
- Across five years, Net Margin topped out at 245829800.0% in Q2 2024 and bottomed at 56849.25% in Q1 2022.
- The 3-year median for Net Margin is 3933.34% (2024), against an average of 49149784.95%.
- The largest YoY upside for Net Margin was 2000000000bps in 2024 against a maximum downside of 1557939bps in 2024.
- A 3-year view of Net Margin shows it stood at 56849.25% in 2022, then surged by 99bps to 579.93% in 2023, then surged by 42389909bps to 245829800.0% in 2024.
- Per Business Quant, the three most recent readings for ADIL's Net Margin are 245829800.0% (Q2 2024), 3933.34% (Q1 2024), and 579.93% (Q2 2023).